CDE: OMS COVID-19 Resurgence Conference: Safely Resuming Practice with a New Normal
04:00 PM-08:00 PM
Virtually presented via BlueJeans
Time: 4:00 – 8:00 PM (EST). The virtual program will begin promptly at 4:00 PM via Bluejeans.
Registration: Free; registration is required.
Register Now »
CE Credits: 3.25 lecture credits
Description
The current COVID-19 crisis has played a major impact on healthcare and society around the world.The OMS COVID-19 Resurgence Conference is a forum for oral and maxillofacial surgeons to come together and learn how we are going to safely resume practice.
Learning Objectives
- Develop an overall understanding of the COVID-19 pandemic and its impact on OMFS resurgence.
- Disseminate strategies to protect OMFS staff, residents and faculty during the resurgence process for the COVID-19 pandemic.
- Understand the criteria for the resumption of surgery from leaders in surgery.
- Learn to implement current and future COVID-19 testing capabilities.
- Create a better understanding of corporate supply chain effects of resuming practice.
- Ensure surgeons are aware of maintenance of wellness during a stressful crisis.
- Find new strategies in office design and workflow to safely care for patients.
- Create a better understanding of health system considerations for resurgence.
- Disseminate international approaches on the resumption of surgery.
Program Schedule
| Time | Topic and Speaker |
| 4:00 PM | Welcome and COVID-19 Resurgence Overview Lee Carrasco, DDS, MD, University of Pennsylvania |
| 4:02 PM | COVID-19 Resurgence for Private Practice Kevin Rieck, DDS, MD, FACS, President, The American College of Oral and Maxillofacial Surgeons |
| 4:13 PM | Marketing Strategies for OMS in the Current Environment Ian McNickle, MBA, Founding Partner, WEO Media – Dental Marketing |
| 4:26 PM | Boston University Resurgence Plans Pushkar Mehra, BDS, DMD, MS, FACS, Chair, Department of Oral & Maxillofacial Surgery, Boston University |
| 4:40 PM | American College of Surgeons: Resumption of Elective Surgery L. Scott Levin, MD, FACS, Chair, Department of Orthopedics, University of Pennsylvania, Vice-Chair, Board of Regents for American College of Surgeons |
| 4:55 PM | Q&A Neeraj Panchal, DDS, MD, MA, University of Pennsylvania |
| 5:05 PM | UTHealth Resurgence Plan Mark E. Wong, DDS, FACS, FACD, Chair and Program Director, Department of Oral & Maxillofacial Surgery, The University of Texas Health Science Center at Houston |
| 5:15 PM | Returning Responsibly to Your OMS Practice – Tips and Tricks Deepak Krishnan, DDS, FACS, Chief & Residency Program Director, Section of Oral & Maxillofacial Surgery, University of Cincinnati Medical Center |
| 5:30 PM | Molecular and Antibody Testing for COVID-19 Irving Nachamkin, DrPH, MPH, D(ABMM), FAAM, FIDSA, Director of the William Pepper Laboratory and the Division of Laboratory Medicine, University of Pennsylvania |
| 5:45 PM | Physician Wellbeing and Leadership in the COVID-19 Pandemic Richard F. Summers, MD, Senior Residency Advisor, Department of Psychiatry, University of Pennsylvania, Treasurer, American Psychiatric Association, Author of “Combating Physician Burnout” |
| 6:00 PM | Q&A Rabie M. Shanti, DMD, MD, University of Pennsylvania |
| 6:15 PM | Hope Regenerates: Geistlich Biomaterials and Regenerative Dentistry in OMS Greg Bosch, CEO, Geistlich Pharma North America, Inc. |
| 6:30 PM | DePuy Synthes CMF’s Commitment to OMFS Throughout COVID-19 Alex Herzlinger, Senior Director, Depuy Synthes CMF/Johnson & Johnson |
| 6:45 PM | The Dental Implant Market during COVID-19 Resurgence Patrik Eriksson, Global President, Nobel Biocare |
| 7:00 PM | Q&A Rania Habib, DDS, MD, University of Pennsylvania |
| 7:15 PM | AAOMS COVID-19 Resurgence Initiative Victor Nannini, DDS, FACS, President, American Association of Oral and Maxillofacial Surgeons (AAOMS) |
| 7:30 PM | COVID-19: The American Dental Association’s Response and Strategies for Practice Recovery Chad Gehani, DDS, President, American Dental Association |
| 7:45 PM | Q&A and Conclusion Neeraj Panchal, DDS, MD, MA, University of Pennsylvania |
THANK YOU TO OUR SPONSORS
DEPUY SYNTHES
GEISTLICH PHARMA NA
NOBEL BIOCARE
University of Pennsylvania School of Dental Medicine is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
University of Pennsylvania School of Dental Medicine designates this activity for 3.25 continuing education credits.